84 related articles for article (PubMed ID: 14971062)
1. Paroxetine and the FDA.
Brent DA
J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):127-8. PubMed ID: 14971062
[No Abstract] [Full Text] [Related]
2. Paroxetine and the FDA.
Riddle MA
J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):128-30. PubMed ID: 14964296
[No Abstract] [Full Text] [Related]
3. Paroxetine and the FDA.
Connor DF
J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):127. PubMed ID: 14726715
[No Abstract] [Full Text] [Related]
4. British panel bans use of antidepressant to treat children.
Abbott A
Nature; 2003 Jun; 423(6942):792. PubMed ID: 12815392
[No Abstract] [Full Text] [Related]
5. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
Greist J; McNamara RK; Mallinckrodt CH; Rayamajhi JN; Raskin J
Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007
[TBL] [Abstract][Full Text] [Related]
6. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
Akiskal HS; Benazzi F
J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043
[TBL] [Abstract][Full Text] [Related]
7. Effects of Food and Drug Administration warnings on antidepressant use in a national sample.
Olfson M; Marcus SC; Druss BG
Arch Gen Psychiatry; 2008 Jan; 65(1):94-101. PubMed ID: 18180433
[TBL] [Abstract][Full Text] [Related]
8. FDA alert on antidepressants for youth.
Mitka M
JAMA; 2003 Nov; 290(19):2534. PubMed ID: 14625316
[No Abstract] [Full Text] [Related]
9. Patients' views on suicidality and antidepressants.
Muroff JR; Kim SY
Psychiatr Serv; 2006 May; 57(5):723-4. PubMed ID: 16675775
[No Abstract] [Full Text] [Related]
10. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
[TBL] [Abstract][Full Text] [Related]
11. FDA and the life-sciences industry: business as usual?
Koski G
Hastings Cent Rep; 2004; 34(5):24-7. PubMed ID: 15553395
[No Abstract] [Full Text] [Related]
12. Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder".
Hashimoto K
J Clin Psychopharmacol; 2009 Aug; 29(4):411-2; author reply 412. PubMed ID: 19593196
[No Abstract] [Full Text] [Related]
13. Restless legs syndrome associated with the combined use of duloxetine plus paroxetine.
Nikolaou KN; Michopoulos I; Douzenis A; Papazahos C; Papageorgiou C; Gournellis R
J Clin Psychopharmacol; 2015 Jun; 35(3):345-6. PubMed ID: 25815756
[No Abstract] [Full Text] [Related]
14. Teen suicide pills? An FDA panel calls for tough labels on antidepressants. What it means for you.
Gorman C
Time; 2004 Sep; 164(13):77. PubMed ID: 15478737
[No Abstract] [Full Text] [Related]
15. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant discontinuation syndrome.
Antai-Otong D
Perspect Psychiatr Care; 2003; 39(3):127-8. PubMed ID: 14606234
[No Abstract] [Full Text] [Related]
17. FDA rejects first cognitive claim for antidepressant.
Mullard A
Nat Rev Drug Discov; 2016 May; 15(5):299. PubMed ID: 27139989
[No Abstract] [Full Text] [Related]
18. [Antidepressants and suicide -- did the FDA Black Box Warning back fire?].
Rihmer Z
Psychiatr Hung; 2014; 29(3):252-6. PubMed ID: 25411222
[No Abstract] [Full Text] [Related]
19. Major medical journals will require registration of clinical trials for publication.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Oct; 15(19):1-2, 6-7. PubMed ID: 15473047
[No Abstract] [Full Text] [Related]
20. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
Mohamed S; Leslie DL; Rosenheck RA
J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
